Goodwill and Other Intangible Assets (Tables)

6 Months Ended

Dec. 29, 2012

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

Changes in the carrying amount of goodwill, by reportable segment, were as follows:

	Consumer Healthcare		Nutritionals		Rx Pharmaceuticals		API		Total
Balance as of June 30, 2012	$	138,910	$	331,744	$	220,769	$	86,334	$	777,757
Business acquisitions	68,229		—		18,823		—		87,052
Currency translation adjustment	2,258		—		3,343		3,894		9,495
Balance as of December 29, 2012	$	209,397	$	331,744	$	242,935	$	90,228	$	874,304

Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]

Other intangible assets and related accumulated amortization consisted of the following:

	December 29, 2012				June 30, 2012				December 31, 2011
	Gross		Accumulated Amortization		Gross		Accumulated Amortization		Gross		Accumulated Amortization
Amortizable intangibles:
Developed product technology/formulation and product rights	$	664,914	$	169,375	$	542,094	$	140,489	$	543,440	$	117,668
Customer relationships	352,655		62,107		341,363		50,757		329,126		41,021
Distribution, license and supply agreements	77,970		27,075		52,609		23,686		52,764		21,496
Non-compete agreements	9,172		4,772		7,804		3,778		6,241		2,986
Trademarks	4,994		710		4,797		704		4,891		696
Total	1,109,705		264,039		948,667		219,414		936,462		183,867
Non-amortizable intangibles:
In-process research and development	35,000		—		35,000		—		35,000		—
Trade names and trademarks	53,500		—		7,365		—		6,591		—
Total other intangible assets	$	1,198,205	$	264,039	$	991,032	$	219,414	$	978,053	$	183,867

Schedule of Intangible Assets, Future Amortization Expense [Table Text Block]

The estimated amortization expense for each of the following five years is as follows:

Fiscal Year	Amount
2013(1)	$	48,000
2014	91,900
2015	90,700
2016	88,700
2017	86,200

⁽¹⁾Reflects remaining six months of fiscal 2013.